1712.5000 47.50 (2.85%)
NSE Jun 03, 2025 15:31 PM
Volume: 58,048
 

1712.50
2.85%
Emkay
MHL’s Q3FY25 EBITDA missed street/our estimates by 9%/4%, with revenue growing 11% YoY driven by B2C revenue improving 15% YoY.
Number of FII/FPI investors decreased from 194 to 173 in Mar 2025 qtr
More from Metropolis Healthcare Ltd.
Recommended